• Exchange: Mexico
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biogen Idec Inc

+ Add to Watchlist

BIIB*:MM

5,218.65 MXN 80.76 1.57%

As of 16:08:54 ET on 12/19/2014.

Snapshot for Biogen Idec Inc (BIIB*)

Open: 5,218.65 Day's Range: 5,218.65 - 5,218.65 Volume: 47
Previous Close: 5,137.89 52wk Range: 3,605.88 - 5,218.65 1-Yr Rtn: +43.99%

Stock Chart for BIIB*

No chart data available.
  • BIIB*:MM 5,218.65
  • 1D
  • 1M
  • 1Y
5,137.89
Interactive BIIB* Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIIB*

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 26.3427
Relative P/E vs. MEXBOL -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 13.5140
Est. PEG Ratio 1.2551
Market Cap (M MXN) 1,232,412.41
Shares Outstanding (M) 236.16
30 Day Average Volume 751
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIIB*

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIIB*

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOAdriana Karaboutis "Andi"Exec VP:Tech & Bus Solutions
More Company Profile & Key Executives for BIIB*

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil